SCHEMBL19863534

SCHEMBL19863534

c1ccc(N(c2ccccc2)c2ccc(-n3c4ccccc4c4c3ccc3c5ccccc5n(-c5ccc(-n6c7ccccc7c7ccccc76)cc5)c34)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.47
▸ L3MBTL1 Q9Y468 2/20 0.47
▸ ATM Q13315 1/20 0.47
▸ PTPN1 P18031 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ HDAC4 P56524 1/20 0.32
▸ MAPK8 P45983 1/20 0.32
▸ JAK2 O60674 1/20 0.31
▸ JAK3 P52333 1/20 0.31
▸ APP P05067 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17019467 1.00 KDM4E (0.47) KDM4EL3MBTL1ATMPTPN1ALDH1A1
SCHEMBL31795 0.99 KDM4E (0.50) KDM4EL3MBTL1ATMPTPN1ALDH1A1
SCHEMBL17189529 0.99 KDM4E (0.50) KDM4EL3MBTL1ATMPTPN1ALDH1A1
SCHEMBL18505027 0.95 L3MBTL1 (0.46) KDM4EL3MBTL1ATMPTPN1ALDH1A1
SCHEMBL24252004 0.94 L3MBTL1 (0.45) KDM4EL3MBTL1ATMPTPN1ALDH1A1
SCHEMBL16773634 0.94 KDM4E (0.45) KDM4EL3MBTL1ATMPTPN1ALDH1A1
SCHEMBL17426374 0.92 KDM4E (0.46) KDM4EL3MBTL1ATMPTPN1ALDH1A1
SCHEMBL15582828 0.92 KDM4E (0.46) KDM4EL3MBTL1ATMPTPN1ALDH1A1
SCHEMBL31869 0.92 L3MBTL1 (0.46) KDM4EL3MBTL1ATMPTPN1ALDH1A1
SCHEMBL16870022 0.91 KDM4E (0.44) KDM4EL3MBTL1ATMPTPN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10600971-B2 Composition for organic optoelectric device and organic optoelectric device and display device SAMSUNG SDI CO., LTD. (KR) 2020-03-24 — — US disclosed
US-20180047916-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2018-02-15 — — US disclosed
US-20180047916-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2018-02-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10600971-B2 Composition for organic optoelectric device and organic optoelectric device and display device OXER1, OR10J3, OR51E2 KDM4E 4718/4885L3MBTL1 4752/4885ATM 4443/4885
US-20180047916-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE OXER1, OR10J3, OR51E2 KDM4E 4718/4885L3MBTL1 4752/4885ATM 4443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback